You are viewing an incomplete version of our website. Please click to reload the website as full version.

Browse our anti-Interleukin 33 (IL33) Antibodies

Full name:
anti-Interleukin 33 Antibodies (IL33)
On are 376 Interleukin 33 (IL33) Antibodies from 30 different suppliers available. Additionally we are shipping Interleukin 33 Proteins (114) and Interleukin 33 Kits (66) and many more products for this protein. A total of 569 Interleukin 33 products are currently listed.
9230117N10Rik, C9orf26, DVS27, Il-33, Il1f11, IL33, NF-HEV, NFEHEV, RGD1311155, RP11-575C20.2

Most Popular Reactivities for anti-Interleukin 33 (IL33) Antibodies

Select your species and application

anti-Human Interleukin 33 Antibodies:

anti-Mouse (Murine) Interleukin 33 Antibodies:

anti-Rat (Rattus) Interleukin 33 Antibodies:

All available anti-Interleukin 33 Antibodies

Go to our pre-filtered search.

Top referenced anti-Interleukin 33 Antibodies

  1. Mouse (Murine) Polyclonal Interleukin 33 Primary Antibody for FACS - ABIN2661329 : Arend, Palmer, Gabay: IL-1, IL-18, and IL-33 families of cytokines. in Immunological reviews 2008 (PubMed)
    Show all 5 references for ABIN2661329

  2. Human Polyclonal Interleukin 33 Primary Antibody for EIA, WB - ABIN500014 : Dinarello: Interleukin-18, a proinflammatory cytokine. in European cytokine network 2000 (PubMed)
    Show all 4 references for ABIN500014

  3. Human Polyclonal Interleukin 33 Primary Antibody for EIA, IF - ABIN500012 : Brint, Xu, Liu, Dunne, McKenzie, ONeill, Liew: ST2 is an inhibitor of interleukin 1 receptor and Toll-like receptor 4 signaling and maintains endotoxin tolerance. in Nature immunology 2004 (PubMed)
    Show all 4 references for ABIN500012

  4. Human Monoclonal Interleukin 33 Primary Antibody for Func, IP - ABIN1169172 : Pace, Di Sano, Sciarrino, Scafidi, Ferraro, Chiappara, Siena, Gangemi, Vitulo, Giarratano, Gjomarkaj: Cigarette smoke alters IL-33 expression and release in airway epithelial cells. in Biochimica et biophysica acta 2014 (PubMed)
    Show all 4 references for ABIN1169172

  5. Human Polyclonal Interleukin 33 Primary Antibody for EIA, WB - ABIN401104 : Hayakawa, Hayakawa, Matsuyama, Tamemoto, Okazaki, Tominaga: Mature interleukin-33 is produced by calpain-mediated cleavage in vivo. in Biochemical and biophysical research communications 2009 (PubMed)
    Show all 4 references for ABIN401104

  6. Human Polyclonal Interleukin 33 Primary Antibody for FACS - ABIN2661328 : McLaren, Michael, Salter, Ashlin, Calder, Miller, Liew, Ramji: IL-33 reduces macrophage foam cell formation. in Journal of immunology (Baltimore, Md. : 1950) 2010 (PubMed)
    Show all 3 references for ABIN2661328

  7. Mouse (Murine) Monoclonal Interleukin 33 Primary Antibody for FACS - ABIN4895750 : Kempuraj, Thangavel, Yang, Pattani, Zaheer, Santillan, Santillan, Zaheer: Dopaminergic Toxin 1-Methyl-4-Phenylpyridinium, Proteins α-Synuclein and Glia Maturation Factor Activate Mast Cells and Release Inflammatory Mediators. in PLoS ONE 2015 (PubMed)
    Show all 2 references for ABIN4895750

  8. Human Polyclonal Interleukin 33 Primary Antibody for IHC, WB - ABIN2784443 : Humphreys, Xu, Hepworth, Liew, Grencis: IL-33, a potent inducer of adaptive immunity to intestinal nematodes. in Journal of immunology (Baltimore, Md. : 1950) 2008 (PubMed)

  9. Human Monoclonal Interleukin 33 Primary Antibody for EIA, WB - ABIN317536 : Baekkevold, Roussigné, Yamanaka, Johansen, Jahnsen, Amalric, Brandtzaeg, Erard, Haraldsen, Girard: Molecular characterization of NF-HEV, a nuclear factor preferentially expressed in human high endothelial venules. in The American journal of pathology 2003 (PubMed)

More Antibodies against Interleukin 33 Interaction Partners

Human Interleukin 33 (IL33) interaction partners

  1. The Interleukin (IL)-33 is an inflammatory cytokine. There are eleven members of the IL-1 (show IL1A Antibodies) family of cytokines and all have important roles in host defense against infections. IL-33 is also associated with autoimmune diseases such as asthma, atopic dermatitis, rheumatoid arthritis, and atherosclerosis.

  2. HIF-1alpha (show HIF1A Antibodies)-dependent IL-33 in IEC functions as a regulatory cytokine in inflamed mucosa of IBD.

  3. Studies provide evidence that in response to tissue damage, IL-33 is released as a nuclear alarmin and triggers innate and adaptive immune responses by binding to its receptor ST2. Recent evidence from clinical and experimental animal studies indicates that the IL-33/ST2 axis is involved in the pathogenesis of chronic kidney disease, renal graft injury, systemic lupus nephritis, and acute kidney injury.[review]

  4. Studies indicate that interleukin (IL)-1beta (show IL1B Antibodies), IL-1alpha, IL-33 and high-mobility group box 1 (HMGB1 (show HMGB1 Antibodies)) enter the extracellular space through mechanisms collectively known as unconventional secretion.

  5. High IL-33 expression is associated with polycystic ovary syndrome.

  6. While serum TSLP (show TSLP Antibodies) levels were unaffected by concomitant allergies and atopic comorbidities, serum levels of IL-31 (show IL31 Antibodies), IL-33 and sST2 (show SSTR2 Antibodies) were affected to a small extent. We found a positive correlation between TSLP (show TSLP Antibodies), IL-31 (show IL31 Antibodies) and IL-33, and an inverse relationship between IL-33 and sST2 (show SSTR2 Antibodies)

  7. IL-33 showed significantly higher expression with increasing tumour grade in both malignant serous and mucinous tumours

  8. IL-33 expression is a novel prognostic marker for malignant salivary gland tumors

  9. The results of this study showed that the elevated IL-33 protein levels in glioma tissues compared to those in normal brain tissues.

  10. IL-33, which is a representative Th2 cytokine, affect as a crucial factor of skin barrier dysfunction by reducing FLG (show FGFR1 Antibodies) expression in human keratinocytes.

Mouse (Murine) Interleukin 33 (IL33) interaction partners

  1. this study shows that IL-33 is likely a major factor in acute respiratory distress syndrome, and the release of HMGB1 (show HMGB1 Antibodies) may be correlated with up-regulation of IL-33 expression

  2. the present study hypothesized that IL-33, as a 'master switch' of tissue repair that is secreted from dying or apoptotic cells, activated the IL-33-ST2-MyD88-TRAF6 pathway, amplified Th2-type responses and was involved in the pulmonary fibrosis process, via its receptor ST2, a stable marker of Th2 cells.

  3. Ras (G12V)-induced cyclin D1 (show CCND1 Antibodies) protein synthesis was markedly suppressed by the knockdown of IL-33.

  4. anti-allergic effect of anti-IL-33 antibodies associated with suppression of immunoglobulin free light chain and nitric oxide synthase (show NOS Antibodies) in a murine model of allergic rhinitis

  5. Data suggest that IL-33 and ST2 function as a developmental switch to license thermogenesis during the perinatal period.

  6. some SNPs of ST2-IL18R1-IL18RAP gene cluster might increase the risk of susceptibility of Graves' disease (GD) and Hashimoto's thyroiditis (HT) in Chinese Han population.

  7. Furthermore, IL-33 injection modulates the innate immune response by polarizing microglia/macrophages toward an antiinflammatory phenotype and reducing the expression of proinflammatory genes, including IL-1beta (show IL1B Antibodies), IL-6 (show IL6 Antibodies), and NLRP3 (show NLRP3 Antibodies), in the cortices of APP (show APP Antibodies)/PS1 (show PSEN1 Antibodies) mice. Collectively, our results demonstrate a potential therapeutic role for IL-33 in AD.

  8. absence of IL-33 has no negative consequences in normal bone homeostasis while high levels of circulating IL-33 contributes to pathological bone loss.

  9. pre-treatment with the ERK1/2 (show MAPK1/3 Antibodies) inhibitor U0126 or anti-IL-33 antibody significantly abolished the ovalbumin (show OVA Antibodies)-induced airway remodeling, increased expressions of IL-33

  10. IL-33 promotes degranulation of bone marrow-derived mast cells and release of cytokines IL-1beta (show IL1B Antibodies), IL-6 (show IL6 Antibodies) and TNF-alpha (show TNF Antibodies).

Pig (Porcine) Interleukin 33 (IL33) interaction partners

  1. IL-33 may be a key molecule operating in eosinophil-mediated fibrosis in high-dose-per fraction irradiated skin.

Interleukin 33 (IL33) Antigen Profile

Antigen Summary

IL33 (MIM 608678) is a member of the IL1 (see MIM 147760) family that potently drives production of T helper-2 (Th2)-associated cytokines (e.g., IL4\; MIM 147780). IL33 is a ligand for IL33R (IL1RL1\; MIM 601203), an IL1 family receptor that is selectively expressed on Th2 cells and mast cells (summary by Yagami et al., 2010

Alternative names and synonyms associated with Interleukin 33 (IL33)

  • interleukin 33 (IL33) antibody
  • interleukin 33 (Il33) antibody
  • interleukin 33-like (LOC100356081) antibody
  • interleukin-33-like (LOC100518643) antibody
  • 9230117N10Rik antibody
  • C9orf26 antibody
  • DVS27 antibody
  • Il-33 antibody
  • Il1f11 antibody
  • IL33 antibody
  • NF-HEV antibody
  • NFEHEV antibody
  • RGD1311155 antibody
  • RP11-575C20.2 antibody

Protein level used designations for anti-Interleukin 33 (IL33) Antibodies

interleukin 33 , IL-33 , interleukin-33 , DVS27-related protein , IL-1F11 , interleukin-1 family member 11 , nuclear factor for high endothelial venules , nuclear factor from high endothelial venules

737537 Pan troglodytes
100171950 Pongo abelii
90865 Homo sapiens
77125 Mus musculus
361749 Rattus norvegicus
100715993 Cavia porcellus
403810 Canis lupus familiaris
507054 Bos taurus
101116705 Ovis aries
100356081 Oryctolagus cuniculus
100518643 Sus scrofa
Selected quality suppliers for anti-Interleukin 33 (IL33) Antibodies
Did you look for something else?